RPID

Rapid Micro Biosystems Inc. Class A Common Stock (RPID) | Rumor.io

Rapid Micro Biosystems

RPID

Attention (50-day avg)0%

Attention rank (50-day avg)#3,808

Bullish sentiment (50-day avg)45%

Price to earnings ratio-1.05

Market capitalization54.9M

Earnings per share-1.11

Dividend yield (TTM)—

Revenue (annual)33.6M

Net income (annual)-47.1M

Social

What share of all stock conversation is about RPID?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Mar 12

Rapid Micro Biosystems reported worse-than-expected Q4 financial results, with a GAAP EPS of -$0.28 and revenue of $11.28M, missing estimates.
The company issued FY26 sales guidance with a midpoint below estimates, expecting total revenue in the range of $37M to $41M, including 30 to 38 Growth Direct system placements.
Rapid Micro Biosystems expects to achieve a gross margin percentage of around 20% in FY26, driven by operating leverage and cost reductions.

Generated by AI

Sentiment

Of the messages about RPID that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	0% -43.75	83.4% -9.78
Bearish	—	—	100% +43.75	16.6% +9.78

Feb 28

Rapid Micro Biosystems, Inc. (RPID) reported a 30% revenue growth in Q4 2024, beating expectations.
The company's partnership with MilliporeSigma (Merck KGaA) is expected to accelerate growth and establish the Growth Direct as the standard in automating microbial quality control.
RPID has a strong balance sheet with $50M in cash, no debt, and a relatively small float, making it a potential candidate for significant price movement.

Generated by AI

Topics

Of the messages about RPID that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	37.87%
Technical Analysis	—	—	—	53.55%
Earnings	—	—	—	3.25%
Analysts	—	—	—	2.66%
Controversies	—	—	—	0%
Macro	—	—	—	2.66%

Feb 28

Rapid Micro Biosystems ($RPID) announced a global distribution and collaboration agreement with Merck KGaA's Life Science business, with guaranteed minimum purchase commitments for the first two years.
The company reported record fourth quarter 2024 total revenue of $8.2 million, representing a 30% increase year-over-year, and provided 2025 guidance with expected total revenue of at least $32.0 million.
Rapid Micro Biosystems' Growth Direct systems are gaining traction, with the company expecting to build on momentum in 2025 through strategic priorities such as accelerating system placements and improving gross margins.

Generated by AI

Community

Of the messages about RPID, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	56.43%
Newcomers	—	—	100%	43.57%

Jan 14

Newcomers are focused on Rapid Micro Biosystems' preliminary Q4 and full-year 2025 revenue, which beat prior guidance and reached record highs.
The company's record number of system placements, with 28 new systems placed in 2025, is a significant positive development.
Rapid Micro Biosystems' recurring revenue grew 15% to approximately $17.8M, indicating a steady and increasing revenue stream.

Generated by AI

News

Roth/MKM initiates Rapid Micro Biosystems stock with buy rating

1d agoInvesting.com

Rapid Micro Biosystems, Inc. (RPID) Presents at Small-Cap Virtual Conference - Slideshow (NASDAQ:RPID) 2026-09-24

2026-09-24. The following slide deck was published by Rapid Micro Biosystems, Inc.

5d agoSeeking Alpha

Rapid Micro Biosystems at Small-Cap Virtual Conference: early growth, margin push

5d agoInvesting.com

After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems (RPID) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

25d agoYahoo Finance

Rapid Micro Biosystems (RPID) Q2 2026 Earnings Call Transcript

Detailed price information for Rapid Micro Biosystems Inc Cl A (RPID-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?

Rapid Micro Biosystems (RPID) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1mo agoYahoo Finance

Also Discussed

Investors talking about RPID also mention

#	Name	Attention
1	Biodesix, Inc.BDSX	0%0
2	Autozi Internet Technology (Global) Ltd. Class AAZI	0%new
3	Brand Engagement Network Inc.BNAI	0%+0
4	Q32 Bio Inc.QTTB	0%+0
5	Gesher I Acquisition Corp.CRGO	0%0
6	Azenta, Inc.AZTA	0%0
7	MaxCyte, Inc.MXCT	0%0
8	Roma Green Finance LimitedROMA	0%0
9	Five Star BancorpFSBC	0%0
10	Personalis Inc.PSNL	0%-0.01

Rapid Micro Biosystems Inc. Class A Common Stock

Healthcare
Medical Devices

Rapid Micro Biosystems Inc. Class A Common Stock represents ownership in Rapid Micro Biosystems, a life sciences technology company focused on automated microbial quality control for the pharmaceutical and biopharmaceutical industries. The company develops mission-critical solutions that help manufacturers detect microbial contamination and support the efficient manufacturing and safe release of healthcare products. Its current offerings include the Growth Direct platform, which combines an automated system, proprietary consumables, software for laboratory information management system connectivity, and validation and support services. These products are used across regulated environments involved in biologics, vaccines, cell and gene therapies, sterile injectables, medical devices, and personal care products. Headquartered in Lexington, Massachusetts, Rapid Micro Biosystems serves customers in the United States and international markets, where faster and more reliable microbial testing plays an important role in modern production workflows.

Website

Location

25 Hartwell Avenue

Lexington, MA, 02421

United States

Social

What share of all stock conversation is about RPID?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Mar 12

Rapid Micro Biosystems reported worse-than-expected Q4 financial results, with a GAAP EPS of -$0.28 and revenue of $11.28M, missing estimates.
The company issued FY26 sales guidance with a midpoint below estimates, expecting total revenue in the range of $37M to $41M, including 30 to 38 Growth Direct system placements.
Rapid Micro Biosystems expects to achieve a gross margin percentage of around 20% in FY26, driven by operating leverage and cost reductions.

Generated by AI

Sentiment

Of the messages about RPID that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	0% -43.75	83.4% -9.78
Bearish	—	—	100% +43.75	16.6% +9.78

Feb 28

Rapid Micro Biosystems, Inc. (RPID) reported a 30% revenue growth in Q4 2024, beating expectations.
The company's partnership with MilliporeSigma (Merck KGaA) is expected to accelerate growth and establish the Growth Direct as the standard in automating microbial quality control.
RPID has a strong balance sheet with $50M in cash, no debt, and a relatively small float, making it a potential candidate for significant price movement.

Generated by AI

Topics

Of the messages about RPID that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	37.87%
Technical Analysis	—	—	—	53.55%
Earnings	—	—	—	3.25%
Analysts	—	—	—	2.66%
Controversies	—	—	—	0%
Macro	—	—	—	2.66%

Feb 28

Rapid Micro Biosystems ($RPID) announced a global distribution and collaboration agreement with Merck KGaA's Life Science business, with guaranteed minimum purchase commitments for the first two years.
The company reported record fourth quarter 2024 total revenue of $8.2 million, representing a 30% increase year-over-year, and provided 2025 guidance with expected total revenue of at least $32.0 million.
Rapid Micro Biosystems' Growth Direct systems are gaining traction, with the company expecting to build on momentum in 2025 through strategic priorities such as accelerating system placements and improving gross margins.

Generated by AI

Community

Of the messages about RPID, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	56.43%
Newcomers	—	—	100%	43.57%

Jan 14

Newcomers are focused on Rapid Micro Biosystems' preliminary Q4 and full-year 2025 revenue, which beat prior guidance and reached record highs.
The company's record number of system placements, with 28 new systems placed in 2025, is a significant positive development.
Rapid Micro Biosystems' recurring revenue grew 15% to approximately $17.8M, indicating a steady and increasing revenue stream.

Generated by AI

Rapid Micro Biosystems

Social

Mar 12

Feb 28

Feb 28

Jan 14

Roth/MKM initiates Rapid Micro Biosystems stock with buy rating

Rapid Micro Biosystems, Inc. (RPID) Presents at Small-Cap Virtual Conference - Slideshow (NASDAQ:RPID) 2026-09-24

Rapid Micro Biosystems at Small-Cap Virtual Conference: early growth, margin push

After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems (RPID) Q2 2026 Earnings Call Transcript

Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?

Also Discussed

Rapid Micro Biosystems Inc. Class A Common Stock

Company Information

Location

Roth/MKM initiates Rapid Micro Biosystems stock with buy rating

Rapid Micro Biosystems, Inc. (RPID) Presents at Small-Cap Virtual Conference - Slideshow (NASDAQ:RPID) 2026-09-24

Rapid Micro Biosystems at Small-Cap Virtual Conference: early growth, margin push

After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems (RPID) Q2 2026 Earnings Call Transcript

Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?

Also Discussed

Social

Mar 12

Feb 28

Feb 28

Jan 14